31 results on '"Bogorad, Roman L"'
Search Results
2. RNAi-nanoparticulate manipulation of gene expression as a new functional genomics tool in the liver
- Author
-
Yin, Hao, Bogorad, Roman L., Barnes, Carmen, Walsh, Stephen, Zhuang, Iris, Nonaka, Hidenori, Ruda, Vera, Kuchimanchi, Satya, Nechev, Lubomir, Akinc, Akin, Xue, Wen, Zerial, Marino, Langer, Robert, Anderson, Daniel G., and Koteliansky, Victor
- Published
- 2016
- Full Text
- View/download PDF
3. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates
- Author
-
Dong, Yizhou, Love, Kevin T., Dorkin, J. Robert, Sirirungruang, Sasilada, Zhang, Yunlong, Chen, Delai, Bogorad, Roman L., Yin, Hao, Chen, Yi, Vegas, Arturo J., Alabi, Christopher A., Sahay, Gaurav, Olejnik, Karsten T., Wang, Weiheng, Schroeder, Avi, Lytton-Jean, Abigail K. R., Siegwart, Daniel J., Akinc, Akin, Barnes, Carmen, Barros, Scott A., Carioto, Mary, Fitzgerald, Kevin, Hettinger, Julia, Kumar, Varun, Novobrantseva, Tatiana I., Qin, June, Querbes, William, Koteliansky, Victor, Langer, Robert, and Anderson, Daniel G.
- Published
- 2014
4. Treatment of erythropoietin deficiency in mice with systemically administered siRNA
- Author
-
Querbes, William, Bogorad, Roman L., Moslehi, Javid, Wong, Jamie, Chan, Amy Y., Bulgakova, Elena, Kuchimanchi, Satya, Akinc, Akin, Fitzgerald, Kevin, Koteliansky, Victor, and Kaelin, William G., Jr
- Published
- 2012
- Full Text
- View/download PDF
5. Local prolactin is a target to prevent expansion of basal/stem cells in prostate tumors
- Author
-
Rouet, Vincent, Bogorad, Roman L., Kayser, Christine, Kessal, Karima, Genestie, Catherine, Bardier, Armelle, Grattan, David R., Kelder, Bruce, Kopchick, John J., Kelly, Paul A., Goffin, Vincent, and Baxter, John D.
- Published
- 2010
6. Identification of a Gain-of-Function Mutation of the Prolactin Receptor in Women with Benign Breast Tumors
- Author
-
Bogorad, Roman L., Courtillot, Carine, Mestayer, Chidi, Bernichtein, Sophie, Harutyunyan, Lilya, Jomain, Jean-Baptiste, Bachelot, Anne, Kuttenn, Frédérique, Kelly, Paul A., Goffin, Vincent, Touraine, Philippe, and Group, The Benign Breast Diseases Study
- Published
- 2008
- Full Text
- View/download PDF
7. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice
- Author
-
Padrissa-Altés, Susagna, Bachofner, Marc, Bogorad, Roman L, Pohlmeier, Lea, Rossolini, Thomas, Böhm, Friederike, Liebisch, Gerhard, Hellerbrand, Claus, Koteliansky, Victor, Speicher, Tobias, and Werner, Sabine
- Published
- 2015
- Full Text
- View/download PDF
8. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo
- Author
-
Zeigerer, Anja, Gilleron, Jerome, Bogorad, Roman L., Marsico, Giovanni, Nonaka, Hidenori, Seifert, Sarah, Epstein-Barash, Hila, Kuchimanchi, Satya, Peng, Chang Geng, Ruda, Vera M., Del Conte-Zerial, Perla, Hengstler, Jan G., Kalaidzidis, Yannis, Koteliansky, Victor, and Zerial, Marino
- Subjects
Liver cells -- Genetic aspects ,Biosynthesis -- Research ,Cell hybridization -- Research ,Lysosomes -- Properties ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
An outstanding question is how cells control the number and size of membrane organelles. The small GTPase Rab5 has been proposed to be a master regulator of endosome biogenesis. Here, to test this hypothesis, we developed a mathematical model of endosome dependency on Rab5 and validated it by titrating down all three Rab5 isoforms in adult mouse liver using state-of-the-art RNA interference technology. Unexpectedly, the endocytic system was resilient to depletion of Rab5 and collapsed only when Rab5 decreased to a critical level. Loss of Rab5 below this threshold caused a marked reduction in the number of early endosomes, late endosomes and lysosomes, associated with a block of low-density lipoprotein endocytosis. Loss of endosomes caused failure to deliver apical proteins to the bile canaliculi, suggesting a requirement for polarized cargo sorting. Our results demonstrate for the first time, to our knowledge, the role of Rab5 as an endosome organizer in vivo and reveal the resilience mechanisms of the endocytic system., What are the molecular mechanisms underlying the biogenesis, number and size of cellular organelles? Organelles of the biosynthetic and endocytic pathway possess a toolbox of coat components, Rab GTPases, SNARE [...]
- Published
- 2012
- Full Text
- View/download PDF
9. Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
- Author
-
Baughman, Joshua M., Perocchi, Fabiana, Girgis, Hany S., Plovanich, Molly, Belcher-Timme, Casey A., Sancak, Yasemin, Bao, X. Robert, Strittmatter, Laura, Goldberger, Olga, Bogorad, Roman L., Koteliansky, Victor, and Mootha, Vamsi K.
- Subjects
Calcium channels -- Physiological aspects -- Research ,Cell membranes -- Physiological aspects -- Research ,Mitochondrial DNA -- Physiological aspects -- Research ,Environmental issues ,Science and technology ,Zoology and wildlife conservation - Abstract
Mitochondria from diverse organisms are capable of transporting large amounts of [Ca.sup.2+] via a ruthenium-red-sensitive, membranepotential-dependent mechanism called the uniporter (1-4). Although the uniporter's biophysical properties have been studied extensively, [...]
- Published
- 2011
- Full Text
- View/download PDF
10. Structure-guided chemical modification of guide RNA enables potent non-viral in vivo genome editing.
- Author
-
Yin, Hao, Song, Chun-Qing, Suresh, Sneha, Wu, Qiongqiong, Walsh, Stephen, Rhym, Luke Hyunsik, Mintzer, Esther, Bolukbasi, Mehmet Fatih, Zhu, Lihua Julie, Kauffman, Kevin, Mou, Haiwei, Oberholzer, Alicia, Ding, Junmei, Kwan, Suet-Yan, Bogorad, Roman L, Zatsepin, Timofei, Koteliansky, Victor, Wolfe, Scot A, Xue, Wen, and Langer, Robert
- Abstract
Efficient genome editing with Cas9-sgRNA in vivo has required the use of viral delivery systems, which have limitations for clinical applications. Translational efforts to develop other RNA therapeutics have shown that judicious chemical modification of RNAs can improve therapeutic efficacy by reducing susceptibility to nuclease degradation. Guided by the structure of the Cas9-sgRNA complex, we identify regions of sgRNA that can be modified while maintaining or enhancing genome-editing activity, and we develop an optimal set of chemical modifications for in vivo applications. Using lipid nanoparticle formulations of these enhanced sgRNAs (e-sgRNA) and mRNA encoding Cas9, we show that a single intravenous injection into mice induces >80% editing of Pcsk9 in the liver. Serum Pcsk9 is reduced to undetectable levels, and cholesterol levels are significantly lowered about 35% to 40% in animals. This strategy may enable non-viral, Cas9-based genome editing in the liver in clinical settings. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Identification of cell cycle-targeting microRNAs through genome-wide screens.
- Author
-
Hydbring, Per, Wang, Yinan, Bogorad, Roman L., Yin, Hao, Anderson, Daniel G., Li, Cheng, and Sicinski, Piotr
- Abstract
By performing nine genome-wide microRNA (miRNA) screens, we recently uncovered a new class of miRNAs, which target multiple cyclins and cyclin-dependent kinases (CDKs). Systemic delivery of selected cell cycle-targeting miRNAs to mouse xenograft models resulted in potent anti-tumorigenic effects without affecting animals' health. Here, we provide an in-depth description of our miRNA screening methodology, analyses of selected cell cycle-targeting miRNAs, and discuss why miRNA therapy might be a viable therapeutic option for cancer patients. [ABSTRACT FROM PUBLISHER]
- Published
- 2017
- Full Text
- View/download PDF
12. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo.
- Author
-
Yin, Hao, Song, Chun-Qing, Dorkin, Joseph R, Zhu, Lihua J, Li, Yingxiang, Wu, Qiongqiong, Park, Angela, Yang, Junghoon, Suresh, Sneha, Bizhanova, Aizhan, Gupta, Ankit, Bolukbasi, Mehmet F, Walsh, Stephen, Bogorad, Roman L, Gao, Guangping, Weng, Zhiping, Dong, Yizhou, Koteliansky, Victor, Wolfe, Scot A, and Langer, Robert
- Published
- 2016
- Full Text
- View/download PDF
13. Regulation of Liver Metabolism by the Endosomal GTPase Rab5.
- Author
-
Zeigerer, Anja, Bogorad, Roman L., Sharma, Kirti, Gilleron, Jerome, Seifert, Sarah, Sales, Susanne, Berndt, Nikolaus, Bulik, Sascha, Marsico, Giovanni, D’Souza, Rochelle C.J., Lakshmanaperumal, Naharajan, Meganathan, Kesavan, Natarajan, Karthick, Sachinidis, Agapios, Dahl, Andreas, Holzhütter, Hermann-Georg, Shevchenko, Andrej, Mann, Matthias, Koteliansky, Victor, and Zerial, Marino
- Abstract
Summary The liver maintains glucose and lipid homeostasis by adapting its metabolic activity to the energy needs of the organism. Communication between hepatocytes and extracellular environment via endocytosis is key to such homeostasis. Here, we addressed the question of whether endosomes are required for gluconeogenic gene expression. We took advantage of the loss of endosomes in the mouse liver upon Rab5 silencing. Strikingly, we found hepatomegaly and severe metabolic defects such as hypoglycemia, hypercholesterolemia, hyperlipidemia, and glycogen accumulation that phenocopied those found in von Gierke’s disease, a glucose-6-phosphatase ( G6Pase ) deficiency. G6Pase deficiency alone can account for the reduction in hepatic glucose output and glycogen accumulation as determined by mathematical modeling. Interestingly, we uncovered functional alterations in the transcription factors, which regulate G6Pase expression. Our data highlight a requirement of Rab5 and the endosomal system for the regulation of gluconeogenic gene expression that has important implications for metabolic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
14. Ionizable Amphiphilic Dendrimer-Based Nanomaterials with Alkyl-Chain-Substituted Amines for Tunable siRNA Delivery to the Liver Endothelium In Vivo.
- Author
-
Khan, Omar F., Zaia, Edmond W., Yin, Hao, Bogorad, Roman L., Pelet, Jeisa M., Webber, Matthew J., Zhuang, Iris, Dahlman, James E., Langer, Robert, and Anderson, Daniel G.
- Subjects
DENDRIMERS ,SMALL interfering RNA ,CELL populations ,NANOPARTICLES ,LIVER cells - Abstract
A library of dendrimers was synthesized and optimized for targeted small interfering RNA (siRNA) delivery to different cell subpopulations within the liver. Using a combinatorial approach, a library of these nanoparticle-forming materials was produced wherein the free amines on multigenerational poly(amido amine) and poly(propylenimine) dendrimers were substituted with alkyl chains of increasing length, and evaluated for their ability to deliver siRNA to liver cell subpopulations. Interestingly, two lead delivery materials could be formulated in a manner to alter their tissue tropism within the liver-with formulations from the same material capable of preferentially delivering siRNA to 1) endothelial cells, 2) endothelial cells and hepatocytes, or 3) endothelial cells, hepatocytes, and tumor cells in vivo. The ability to broaden or narrow the cellular destination of siRNA within the liver may provide a useful tool to address a range of liver diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
15. Loss of α-catenin elicits a cholestatic response and impairs liver regeneration.
- Author
-
Keira Joann Herr, Ying-hung Nicole Tsang, Joanne Wei En Ong, Qiushi Li, Lai Lai Yap, Weimiao Yu, Hao Yin, Bogorad, Roman L., Dahlman, James E., Yee Gek Chan, Boon Huat Bay, Singaraja, Roshni, Anderson, Daniel G., Koteliansky, Victor, Viasnoff, Virgile, and Thiery, Jean Paul
- Subjects
LIVER regeneration ,CATENINS ,LIVER disease treatment ,LIVER cells ,CELL communication ,CELL size ,CELL proliferation - Abstract
The liver is unique in its capacity to regenerate after injury, during which hepatocytes actively divide and establish cell-cell contacts through cell adhesion complexes. Here, we demonstrate that the loss of α-catenin, a well-established adhesion component, dramatically disrupts liver regeneration. Using a partial hepatectomy model, we show that regenerated livers from α-catenin knockdown mice are grossly larger than control regenerated livers, with an increase in cell size and proliferation. This increased proliferation correlated with increased YAP activation, implicating α-catenin in the Hippo/YAP pathway. Additionally, α-catenin knockdown mice exhibited a phenotype reminiscent of clinical cholestasis, with drastically altered bile canaliculi, elevated levels of bile components and signs of jaundice and inflammation. The disrupted regenerative capacity is a result of actin cytoskeletal disorganisation, leading to a loss of apical microvilli, dilated lumens in the bile canaliculi, and leaky tight junctions. This study illuminates a novel, essential role for α-catenin in liver regeneration. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
16. Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo
- Author
-
Yin, Hao, Song, Chun-Qing, Dorkin, Joseph R, Zhu, Lihua J, Li, Yingxiang, Wu, Qiongqiong, Park, Angela, Yang, Junghoon, Suresh, Sneha, Bizhanova, Aizhan, Gupta, Ankit, Bolukbasi, Mehmet F, Walsh, Stephen, Bogorad, Roman L, Gao, Guangping, Weng, Zhiping, Dong, Yizhou, Koteliansky, Victor, Wolfe, Scot A, Langer, Robert, Xue, Wen, and Anderson, Daniel G
- Abstract
The combination of Cas9, guide RNA and repair template DNA can induce precise gene editing and the correction of genetic diseases in adult mammals. However, clinical implementation of this technology requires safe and effective delivery of all of these components into the nuclei of the target tissue. Here, we combine lipid nanoparticle–mediated delivery of Cas9 mRNA with adeno-associated viruses encoding a sgRNA and a repair template to induce repair of a disease gene in adult animals. We applied our delivery strategy to a mouse model of human hereditary tyrosinemia and show that the treatment generated fumarylacetoacetate hydrolase (Fah)-positive hepatocytes by correcting the causative Fah-splicing mutation. Treatment rescued disease symptoms such as weight loss and liver damage. The efficiency of correction was >6% of hepatocytes after a single application, suggesting potential utility of Cas9-based therapeutic genome editing for a range of diseases.
- Published
- 2017
- Full Text
- View/download PDF
17. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
- Author
-
Dahlman, James E., Barnes, Carmen, Khan, Omar F., Thiriot, Aude, Jhunjunwala, Siddharth, Shaw, Taylor E., Xing, Yiping, Sager, Hendrik B., Sahay, Gaurav, Speciner, Lauren, Bader, Andrew, Bogorad, Roman L., Yin, Hao, Racie, Tim, Dong, Yizhou, Jiang, Shan, Seedorf, Danielle, Dave, Apeksha, Singh Sandhu, Kamaljeet, and Webber, Matthew J.
- Subjects
SMALL interfering RNA ,ENDOTHELIAL cells ,NANOPARTICLES ,MOLECULAR weights ,GENE expression - Abstract
Dysfunctional endothelium contributes to more diseases than any other tissue in the body. Small interfering RNAs (siRNAs) can help in the study and treatment of endothelial cells in vivo by durably silencing multiple genes simultaneously, but efficient siRNA delivery has so far remained challenging. Here, we show that polymeric nanoparticles made of low-molecular-weight polyamines and lipids can deliver siRNA to endothelial cells with high efficiency, thereby facilitating the simultaneous silencing of multiple endothelial genes in vivo. Unlike lipid or lipid-like nanoparticles, this formulation does not significantly reduce gene expression in hepatocytes or immune cells even at the dosage necessary for endothelial gene silencing. These nanoparticles mediate the most durable non-liver silencing reported so far and facilitate the delivery of siRNAs that modify endothelial function in mouse models of vascular permeability, emphysema, primary tumour growth and metastasis. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
18. The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo.
- Author
-
Ruda, Vera M., Chandwani, Rohit, Sehgal, Alfica, Bogorad, Roman L., Akinc, Akin, Charisse, Klaus, Tarakhovsky, Alexander, Novobrantseva, Tatiana I., and Koteliansky, Victor
- Subjects
ARGONAUTE proteins ,RNA interference ,REPORTER genes ,TRANSGENES ,NON-coding RNA ,GENE targeting ,GENE expression - Abstract
Argonaute 2 (Ago2) is the only mammalian Ago protein capable of mRNA cleavage. It has been reported that the activity of the short interfering RNA targeting coding sequence (CDS), but not 3′ untranslated region (3′UTR) of an mRNA, is solely dependent on Ago2 in vitro. These studies utilized extremely high doses of siRNAs and overexpressed Ago proteins, as well as were directed at various highly expressed reporter transgenes. Here we report the effect of Ago2 in vivo on targeted knockdown of several endogenous genes by siRNAs, targeting both CDS and 3′UTR. We show that siRNAs targeting CDS lose their activity in the absence of Ago2, whereas both Ago1 and Ago3 proteins contribute to residual 3′UTR-targeted siRNA-mediated knockdown observed in the absence of Ago2 in mouse liver. Our results provide mechanistic insight into two components mediating RNAi under physiological conditions: mRNA cleavage dependent and independent. In addition our results contribute a novel consideration for designing most efficacious siRNA molecules with the preference given to 3′UTR targeting as to harness the activity of several Ago proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
19. Lipopeptide nanoparticles for potent and selective siRNA delivery in rodents and nonhuman primates.
- Author
-
Yizhou Dong, Love, Kevin T., Dorkin, J. Robert, Sirirungruang, Sasilada, Yunlong Zhang, Delai Chen, Bogorad, Roman L., Hao Yin, Yi Chen, Vegas, Arturo J., Alabi, Christopher A., Sahay, Gaurav, Olejnik, Karsten T., Weiheng Wang, Schroeder, Avi, Lytton-Jean, Abigail K. R., Siegwart, Daniel J., Akinc, Akin, Barnes, Carmen, and Barros, Scott A.
- Subjects
SMALL interfering RNA ,NANOPARTICLES ,GENETIC disorder treatment ,LIPOPROTEINS ,LABORATORY mice ,APOLIPOPROTEIN E ,ENDOTHELIAL cells ,THERAPEUTICS - Abstract
siRNA therapeutics have promise for the treatment of a wide range of genetic disorders. Motivated by lipoproteins, we report lipopeptide nanoparticles as potent and selective siRNA carriers with a wide therapeutic index. Lead material cKK-E12 showed potent silencing effects in mice (ED
50 ∼ 0.002 mg/kg), rats (ED50 < 0.01 mg/kg), and nonhuman primates (over 95% silencing at 0.3 mg/kg). Apolipoprotein E plays a significant role in the potency of cKK-E12 both in vitro and in vivo. cKK-E12 was highly selective toward liver parenchymal cell in vivo, with orders of magnitude lower doses needed to silence in hepatocytes compared with endothelial cells and immune cells in different organs. Toxicity studies showed that cKK-E12 was well tolerated in rats at a dose of 1 mg/kg (over 100-fold higher than the ED50 ). To our knowledge, this is the most efficacious and selective nonviral siRNA delivery system for gene silencing in hepatocytes reported to date. [ABSTRACT FROM AUTHOR]- Published
- 2014
- Full Text
- View/download PDF
20. MICU2, a Paralog of MICU1, Resides within the Mitochondrial Uniporter Complex to Regulate Calcium Handling.
- Author
-
Plovanich, Molly, Bogorad, Roman L., Sancak, Yasemin, Kamer, Kimberli J., Strittmatter, Laura, Li, Andrew A., Girgis, Hany S., Kuchimanchi, Satya, De Groot, Jack, Speciner, Lauren, Taneja, Nathan, OShea, Jonathan, Koteliansky, Victor, and Mootha, Vamsi K.
- Subjects
- *
MITOCHONDRIAL membranes , *CALCIUM channels , *BIOINFORMATICS , *CELL death , *ADENOSINE triphosphate , *CHEMICAL synthesis , *GENOMES , *CHROMOSOME duplication - Abstract
Mitochondrial calcium uptake is present in nearly all vertebrate tissues and is believed to be critical in shaping calcium signaling, regulating ATP synthesis and controlling cell death. Calcium uptake occurs through a channel called the uniporter that resides in the inner mitochondrial membrane. Recently, we used comparative genomics to identify MICU1 and MCU as the key regulatory and putative pore-forming subunits of this channel, respectively. Using bioinformatics, we now report that the human genome encodes two additional paralogs of MICU1, which we call MICU2 and MICU3, each of which likely arose by gene duplication and exhibits distinct patterns of organ expression. We demonstrate that MICU1 and MICU2 are expressed in HeLa and HEK293T cells, and provide multiple lines of biochemical evidence that MCU, MICU1 and MICU2 reside within a complex and cross-stabilize each other's protein expression in a cell-type dependent manner. Using in vivo RNAi technology to silence MICU1, MICU2 or both proteins in mouse liver, we observe an additive impairment in calcium handling without adversely impacting mitochondrial respiration or membrane potential. The results identify MICU2 as a new component of the uniporter complex that may contribute to the tissue-specific regulation of this channel. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
21. Prolactin Levels and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women.
- Author
-
Reuwer, Anne Q., Twickler, Marcel ThB, Hutten, Barbara A., Molema, Frederique W., Wareham, Nicholas J., Dallinga-Thie, Geesje M., Bogorad, Roman L., Goffin, Vincent, Smink-Bol, Mijke, Kastelein, John J.P., Boekholdt, S. Matthijs, and Kay-Tee Khaw
- Subjects
PROLACTIN ,PITUITARY hormones ,GONADOTROPIN ,CORONARY disease ,HEART diseases - Abstract
The article investigates whether prolactin levels are associated with the occurrence of coronary artery disease (CAD). The method involves a nested case control study among healthy individuals aged 45 to 79 who developed fatal or non fatal CAD. Results suggest that elevated systemic prolactin levels do not predict CAD in the general population although prolactin receptors were found in human atherosclerotic plaques that may indicate a role for prolactin in atherosclerotic plaque development.
- Published
- 2009
- Full Text
- View/download PDF
22. Nanoparticle-formulated siRNA targeting integrins inhibits hepatocellular carcinoma progression in mice
- Author
-
Bogorad, Roman L, Yin, Hao, Zeigerer, Anja, Nonaka, Hidenori, Ruda, Vera, Zerial, Marino, Anderson, Daniel G, and Koteliansky, Victor
- Abstract
Integrins play an important role during development, regulating cell differentiation, proliferation and survival. Here we show that knockdown of integrin subunits slows down the progression of hepatocellular carcinoma (HCC). Using nanoparticulate delivery of short interfering RNAs targeting β1 and αv integrin subunits we downregulate all integrin receptors in hepatocytes. Short-term integrin knockdown (two weeks) does not cause apparent structural or functional perturbations of normal liver tissue. Alterations in liver morphology accumulate upon sustained integrin downregulation (seven weeks). The integrin knockdown leads to significant retardation of HCC progression, reducing proliferation and increasing tumour cell death. This tumour retardation is accompanied by reduced activation of MET oncogene as well as expression of its mature form on the cell surface. Our data suggest that transformed proliferating cells from HCC are more sensitive to knockdown of integrins than normal quiescent hepatocytes, highlighting the potential of siRNA-mediated inhibition of integrins as an anti-cancer therapeutic approach.
- Published
- 2014
- Full Text
- View/download PDF
23. Loss of α-catenin elicits a cholestatic response and impairs liver regeneration
- Author
-
Herr, Keira Joann, Tsang, Ying-hung Nicole, Ong, Joanne Wei En, Li, Qiushi, Yap, Lai Lai, Yu, Weimiao, Yin, Hao, Bogorad, Roman L., Dahlman, James E., Chan, Yee Gek, Bay, Boon Huat, Singaraja, Roshni, Anderson, Daniel G., Koteliansky, Victor, Viasnoff, Virgile, and Thiery, Jean Paul
- Abstract
The liver is unique in its capacity to regenerate after injury, during which hepatocytes actively divide and establish cell-cell contacts through cell adhesion complexes. Here, we demonstrate that the loss of α-catenin, a well-established adhesion component, dramatically disrupts liver regeneration. Using a partial hepatectomy model, we show that regenerated livers from α-catenin knockdown mice are grossly larger than control regenerated livers, with an increase in cell size and proliferation. This increased proliferation correlated with increased YAP activation, implicating α-catenin in the Hippo/YAP pathway. Additionally, α-catenin knockdown mice exhibited a phenotype reminiscent of clinical cholestasis, with drastically altered bile canaliculi, elevated levels of bile components and signs of jaundice and inflammation. The disrupted regenerative capacity is a result of actin cytoskeletal disorganisation, leading to a loss of apical microvilli, dilated lumens in the bile canaliculi, and leaky tight junctions. This study illuminates a novel, essential role for α-catenin in liver regeneration.
- Published
- 2014
- Full Text
- View/download PDF
24. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
- Author
-
Yin, Hao, Xue, Wen, Chen, Sidi, Bogorad, Roman L, Benedetti, Eric, Grompe, Markus, Koteliansky, Victor, Sharp, Phillip A, Jacks, Tyler, and Anderson, Daniel G
- Subjects
GENETIC mutation ,LIVER cells ,TYROSINEMIA ,LABORATORY mice ,WEIGHT loss ,MEDICAL genetics ,HUMAN genetics - Abstract
We demonstrate CRISPR-Cas9-mediated correction of a Fah mutation in hepatocytes in a mouse model of the human disease hereditary tyrosinemia. Delivery of components of the CRISPR-Cas9 system by hydrodynamic injection resulted in initial expression of the wild-type Fah protein in ∼1/250 liver cells. Expansion of Fah-positive hepatocytes rescued the body weight loss phenotype. Our study indicates that CRISPR-Cas9-mediated genome editing is possible in adult animals and has potential for correction of human genetic diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
25. Systemic RNAi-mediated Gene Silencing in Nonhuman Primate and Rodent Myeloid Cells
- Author
-
Novobrantseva, Tatiana I, Borodovsky, Anna, Wong, Jamie, Klebanov, Boris, Zafari, Mohammad, Yucius, Kristina, Querbes, William, Ge, Pei, Milstein, Stuart, Speciner, Lauren, Duncan, Rick, Barros, Scott, Basha, Genc, Cullis, Pieter, Akinc, Akin, Donahoe, Jessica S, Narayanannair Jayaprakash, K, Jayaraman, Muthusamy, Bogorad, Roman L, Love, Kevin, Whitehead, Katie, Levins, Chris, Manoharan, Muthiah, de Fougerolles, Antonin, Koteliansky, Victor, Ruda, Vera M., Swirski, Filip K., Weissleder, Ralph, Langer, Robert S., Anderson, Daniel Griffith, and Nahrendorf, Matthias
- Abstract
Leukocytes are central regulators of inflammation and the target cells of therapies for key diseases, including autoimmune, cardiovascular, and malignant disorders. Efficient in vivo delivery of small interfering RNA (siRNA) to immune cells could thus enable novel treatment strategies with broad applicability. In this report, we develop systemic delivery methods of siRNA encapsulated in lipid nanoparticles (LNP) for durable and potent in vivo RNA interference (RNAi)-mediated silencing in myeloid cells. This work provides the first demonstration of siRNA-mediated silencing in myeloid cell types of nonhuman primates (NHPs) and establishes the feasibility of targeting multiple gene targets in rodent myeloid cells. The therapeutic potential of these formulations was demonstrated using siRNA targeting tumor necrosis factor-α (TNFα) which induced substantial attenuation of disease progression comparable to a potent antibody treatment in a mouse model of rheumatoid arthritis (RA). In summary, we demonstrate a broadly applicable and therapeutically relevant platform for silencing disease genes in immune cells.
- Published
- 2012
- Full Text
- View/download PDF
26. Corrigendum: Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
- Author
-
Yin, Hao, Xue, Wen, Chen, Sidi, Bogorad, Roman L, Benedetti, Eric, Grompe, Markus, Koteliansky, Victor, Sharp, Phillip A, Jacks, Tyler, and Anderson, Daniel G
- Subjects
ANIMAL disease models ,GENOMICS - Abstract
A correction to the article "Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype" published in a previous issue of 2014 is presented.
- Published
- 2014
- Full Text
- View/download PDF
27. Knockdown and knockout of β1-integrin in hepatocytes impairs liver regeneration through inhibition of growth factor signalling.
- Author
-
Speicher, Tobias, Siegenthaler, Beat, Bogorad, Roman L., Ruppert, Raphael, Petzold, Tobias, Padrissa-Altes, Susagna, Bachofner, Marc, Anderson, Daniel G., Koteliansky, Victor, Fässler, Reinhard, and Werner, Sabine
- Published
- 2014
- Full Text
- View/download PDF
28. Large-Scale Quantitative Proteomics Identifies the Ubiquitin Ligase Nedd4-1 as an Essential Regulator of Liver Regeneration.
- Author
-
Bachofner, Marc, Speicher, Tobias, Bogorad, Roman L., Muzumdar, Sukalp, Derrer, Carina P., Hürlimann, Fabrizio, Böhm, Friederike, Nanni, Paolo, Kockmann, Tobias, Kachaylo, Ekaterina, Meyer, Michael, Padrissa-Altés, Susagna, Graf, Rolf, Anderson, Daniel G., Koteliansky, Victor, auf dem Keller, Ulrich, and Werner, Sabine
- Subjects
- *
LIVER regeneration , *ORCHESTRATORS , *PROTEASOMES , *HEPATECTOMY , *CELL proliferation , *SMALL interfering RNA - Abstract
Summary The liver is the only organ in mammals that fully regenerates even after major injury. To identify orchestrators of this regenerative response, we performed quantitative large-scale proteomics analysis of cytoplasmic and nuclear fractions from normal versus regenerating mouse liver. Proteins of the ubiquitin-proteasome pathway were rapidly upregulated after two-third hepatectomy, with the ubiquitin ligase Nedd4-1 being a top hit. In vivo knockdown of Nedd4-1 in hepatocytes through nanoparticle-mediated delivery of small interfering RNA caused severe liver damage and inhibition of cell proliferation after hepatectomy, resulting in liver failure. Mechanistically, we demonstrate that Nedd4-1 is required for efficient internalization of major growth factor receptors involved in liver regeneration and their downstream mitogenic signaling. These results highlight the power of large-scale proteomics to identify key players in liver regeneration and the importance of posttranslational regulation of growth factor signaling in this process. Finally, they identify an essential function of Nedd4-1 in tissue repair. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
29. Residue 146 regulates prolactin receptor folding, basal activity and ligand-responsiveness: Potential implications in breast tumorigenesis.
- Author
-
Zhang, Chi, Cherifi, Ibtissem, Nygaard, Mads, Haxholm, Gitte W., Bogorad, Roman L., Bernadet, Marie, England, Patrick, Broutin, Isabelle, Kragelund, Birthe B., Guidotti, Jacques-Emmanuel, and Goffin, Vincent
- Subjects
- *
PROLACTIN receptors , *PROTEIN folding , *LIGANDS (Biochemistry) , *BREAST cancer , *DIMERIZATION , *NUCLEAR magnetic resonance spectroscopy , *GENETIC mutation - Abstract
PRLR I146L is the first identified gain-of-function variant of the prolactin receptor (PRLR) that was proposed to be associated with benign breast tumorigenesis. Structural investigations suggested this hydrophobic core position in the extracellular D2 domain to be linked to receptor dimerization. Here, we used a mutational approach to address how the conservative I-to-L substitution induced constitutive activity. Using cell-based assays of different I146-PRLR variants in combination with spectroscopic/nuclear magnetic resonance analyses we found that chemical manipulation of position 146 profoundly altered folding, PRL-responsiveness, and ligand-independent activity of the receptor in a mutation-specific manner. Together, these data further add to the critical role of position 146, showing it to also be crucial to structural integrity thereby imposing on the biological PRLR properties. When stably introduced in MCF-7 (luminal) and MDA-MB231 (mesenchymal) breast cancer cells, the most potent of the PRL-insensitive mutants (PRLR I146D ) had minimal impact on cell proliferation and cell differentiation status. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
30. The Roles of Individual Mammalian Argonautes in RNA Interference In Vivo.
- Author
-
Ruda, Vera M., Chandwani, Rohit, Sehgal, Alfica, Bogorad, Roman L., Akinc, Akin, Charisse, Klaus, Tarakhovsky, Alexander, Novobrantseva, Tatiana I., and Koteliansky, Victor
- Subjects
- *
ARGONAUTE proteins , *RNA interference , *REPORTER genes , *TRANSGENES , *NON-coding RNA , *GENE targeting , *GENE expression - Abstract
Argonaute 2 (Ago2) is the only mammalian Ago protein capable of mRNA cleavage. It has been reported that the activity of the short interfering RNA targeting coding sequence (CDS), but not 3′ untranslated region (3′UTR) of an mRNA, is solely dependent on Ago2 in vitro. These studies utilized extremely high doses of siRNAs and overexpressed Ago proteins, as well as were directed at various highly expressed reporter transgenes. Here we report the effect of Ago2 in vivo on targeted knockdown of several endogenous genes by siRNAs, targeting both CDS and 3′UTR. We show that siRNAs targeting CDS lose their activity in the absence of Ago2, whereas both Ago1 and Ago3 proteins contribute to residual 3′UTR-targeted siRNA-mediated knockdown observed in the absence of Ago2 in mouse liver. Our results provide mechanistic insight into two components mediating RNAi under physiological conditions: mRNA cleavage dependent and independent. In addition our results contribute a novel consideration for designing most efficacious siRNA molecules with the preference given to 3′UTR targeting as to harness the activity of several Ago proteins. [ABSTRACT FROM AUTHOR]
- Published
- 2014
- Full Text
- View/download PDF
31. Cell-Cycle-Targeting MicroRNAs as Therapeutic Tools against Refractory Cancers.
- Author
-
Hydbring, Per, Wang, Yinan, Fassl, Anne, Li, Xiaoting, Matia, Veronica, Otto, Tobias, Choi, Yoon Jong, Sweeney, Katharine E., Suski, Jan M., Yin, Hao, Bogorad, Roman L., Goel, Shom, Yuzugullu, Haluk, Kauffman, Kevin J., Yang, Junghoon, Jin, Chong, Li, Yingxiang, Floris, Davide, Swanson, Richard, and Ng, Kimmie
- Subjects
- *
CYCLINS , *CYCLIN-dependent kinases , *MICRORNA , *HUMAN cell cycle , *CANCER prevention , *THERAPEUTICS ,TUMOR prevention - Abstract
Summary Cyclins and cyclin-dependent kinases (CDKs) are hyperactivated in numerous human tumors. To identify means of interfering with cyclins/CDKs, we performed nine genome-wide screens for human microRNAs (miRNAs) directly regulating cell-cycle proteins. We uncovered a distinct class of miRNAs that target nearly all cyclins/CDKs, which are very effective in inhibiting cancer cell proliferation. By profiling the response of over 120 human cancer cell lines, we derived an expression-based algorithm that can predict the response of tumors to cell-cycle-targeting miRNAs. Using systemic administration of nanoparticle-formulated miRNAs, we inhibited tumor progression in seven mouse xenograft models, including three treatment-refractory patient-derived tumors, without affecting normal tissues. Our results highlight the utility of using cell-cycle-targeting miRNAs for treatment of refractory cancer types. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.